sabrina.ronen@radiology.ucsf.edu
(415) 514-4839 (voice)
(415) 514-2550 (fax)

Box 2532, UCSF; San Francisco, CA 94143-2532

Hebrew University, Israel, BSc, 1981, Chemistry/Biochemistry
San Jose State University, California, MS, 1986, Chemistry
Weizmann Institute of Science, Israel, PhD, 1991, Chemical Physics

Pesek JJ, Ronen SM, Alcaraz A. The study of ternary metal-protein-ligand complexes using 81Br magnetic resonance Applied Spectroscopy, 1987;41:865-69.

Ronen S, Degani H. Studies of the metabolism of human breast cancer spheroids by NMR. Magn Reson Med, Nov/1989;12(2):274-81.

Ronen SM, Stier A, Degani H. NMR studies of the lipid metabolism of T47D human breast cancer spheroids. FEBS Lett, Jun/18/1990;266(1-2):147-9.

Ronen SM, Rushkin E, Degani H. Lipid metabolism in T47D human breast cancer cells: 31P and 13C-NMR studies of choline and ethanolamine uptake. Biochim Biophys Acta, Oct/16/1991;1095(1):5-16.

Ronen SM, Rushkin E, Degani H. Lipid metabolism in large T47D human breast cancer spheroids: 31P- and 13C-NMR studies of choline and ethanolamine uptake. Biochim Biophys Acta, Mar/20/1992;1138(3):203-12.

Ronen SM, Degani H. The application of 13C NMR to the characterization of phospholipid metabolism in cells. Magn Reson Med, Jun/1992;25(2):384-9.

Ronen SM, Volk A, Mispelter J. Comparative NMR study of a differentiated rat hepatoma and its dedifferentiated subclone cultured as spheroids and as implanted tumors. NMR Biomed, Sep/1994;7(6):278-86.

Ronen SM, Raine AEG, Yacoub MH, Seymour A-ML. Post-ischemic PCr recovery is correlated with hypertrophy in uremic hearts The Journal of Heart Failure, 1996;3:22.

Smith TAD, Ronen SM, Title JC, McCready VR. Deoxyglucose uptake by apoptosing and proliferating colonic tumour cells Eur J Nucl Med, 1998;2S:S11, 36.

Leach MO, Verrill M, Glaholm J, Smith TA, Collins DJ, Payne GS, Sharp JC, Ronen SM, McCready VR, Powles TJ, Smith IE. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed, Nov/1998;11(7):314-40.

Maisey N, Smith TA, Ronen SM, Leach MO. Do early change in deoxyglucose uptake vary with therapy British J Cancer, 1999;80(Supp2):108.

Ronen SM, DiStefano F, McCoy CL, Robertson D, Smith TA, Al-Saffar NM, Titley J, Cunningham DC, Griffiths JR, Leach MO, Clarke PA. Magnetic resonance detects metabolic changes associated with chemotherapy-induced apoptosis. Br J Cancer, Jun/1999;80(7):1035-41.

Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JA, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM. Applications of magnetic resonance in model systems: cancer therapeutics. Neoplasia, 2000;2(1-2):152-65.

Smith TA, Maisey NR, Titley JC, Jackson LE, Leach MO, Ronen SM. Treatment of SW620 cells with Tomudex and oxaliplatin induces changes in 2-deoxy-D-glucose incorporation associated with modifications in glucose transport. J Nucl Med, Oct/2000;41(10):1753-9.

Ronen SM, Leach MO. Imaging biochemistry: applications to breast cancer. Breast Cancer Res, 2001;3(1):36-40.

Ronen SM, Jackson LE, Beloueche M, Leach MO. Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells. Br J Cancer, Mar/2/2001;84(5):691-6.

Al-Saffar NM, Titley JC, Robertson D, Clarke PA, Jackson LE, Leach MO, Ronen SM. Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells. Br J Cancer, Mar/18/2002;86(6):963-70.

Chung YL, Troy H, Banerji U, Jackson LE, Walton MI, Stubbs M, Griffiths JR, Judson IR, Leach MO, Workman P, Ronen SM. Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino,17-demethoxygeldanamycin (17AAG) in human colon cancer models. J Natl Cancer Inst, Nov/5/2003;95(21):1624-33.

Beloueche-Babari M, Jackson LE, Al-Saffar NM, Workman P, Leach MO, Ronen SM. Magnetic resonance spectroscopy monitoring of mitogen-activated protein kinase signaling inhibition. Cancer Res, Apr/15/2005;65(8):3356-63.

Beloueche-Babari M, Jackson LE, Al-Saffar NM, Eccles SA, Raynaud FI, Workman P, Leach MO, Ronen SM. Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cells. Mol Cancer Ther, Jan/2006;5(1):187-96.

Sankaranarayanapillai M, Tong WP, Maxwell DS, Pal A, Pang J, Bornmann WG, Gelovani JG, Ronen SM. Detection of histone deacetylase inhibition by noninvasive magnetic resonance spectroscopy. Mol Cancer Ther, May/2006;5(5):1325-34.

Sankaranarayanapillai M, Tong W, Yuan Q, Bankson J, Dafni H, Bornmann W, Soghomonyan S, Pal A, Ramirez M, Webb D, Kaluarachchi K, Gelovani J, Ronen SM. Monitoring histone deacetylase inhibition in vivo: a noninvasive magnetic resonance spectroscopy method Molecular Imaging, (In Press) , 2008;0:0.

Dafni H, Kim S-J, Bankson JA, Sankaranarayanapillai M, Ronen SM. Macromolecular DCE-MRI detects reduced vascular permeability in a prostate cancer bone metastasis model following anti-PDGFR therapy, indicating a drop in VEGFR activation Magnetic Resonance in Medicine, (In Press) , 2008;0:0.

James Ross, Amer M. Najjar, Madhuri Sankaranarayanapillai, William P. Tong, Kumaralal Kaluarachchi, Sabrina M. Ronen. Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine Molecular Cancer Therapeutics, (In Press) , 2008;0:0.

6/9/08